Karl A. Merrick

1.2k total citations
14 papers, 798 citations indexed

About

Karl A. Merrick is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Karl A. Merrick has authored 14 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Karl A. Merrick's work include Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (5 papers) and Microtubule and mitosis dynamics (5 papers). Karl A. Merrick is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (5 papers) and Microtubule and mitosis dynamics (5 papers). Karl A. Merrick collaborates with scholars based in United States, Canada and Ireland. Karl A. Merrick's co-authors include Robert P. Fisher, Stéphane Larochelle, Lara Wohlbold, Chao Zhang, Kevan M. Shokat, Jasmina J. Allen, Marie‐Emilie Terret, Prasad V. Jallepalli, Michael B. Yaffe and Sandra Morandell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Cancer Cell.

In The Last Decade

Karl A. Merrick

14 papers receiving 788 citations

Peers

Countries citing papers authored by Karl A. Merrick

Since Specialization

Citations

This map shows the geographic impact of Karl A. Merrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl A. Merrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl A. Merrick more than expected).

Fields of papers citing papers by Karl A. Merrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl A. Merrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl A. Merrick. The network helps show where Karl A. Merrick may publish in the future.

Co-authorship network of co-authors of Karl A. Merrick

This figure shows the co-authorship network connecting the top 25 collaborators of Karl A. Merrick. A scholar is included among the top collaborators of Karl A. Merrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl A. Merrick. Karl A. Merrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	An RNA damage response network mediates the lethality of 5-FU in colorectal cancer 2024 ·Cell Reports Medicine ·(unknown), Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D. Handly, Jesse C. Patterson, Ian G. Cannell, Lucía Suárez-López, Aaron M. Hosios, (unknown), Donald S. Kirkpatrick, Kebing Yu, Christopher M. Rose, Jonathan M. Hernandez, (unknown), Adam C. Palmer, Matthew G. Vander Heiden, Ömer Yılmaz, Michael B. Yaffe	11
2	Abstract 4410: Predictive model of palbociclib response reveals indications in which CDK4/6 inhibitor can be a potential combination partner 2019 ·Cancer Research ·Marc Hafner, Nicholas Dompe, Wei Zhou, Eva Lin, Milena Dürrbaum, Anneleen Daemen, Melissa R. Junttila, Ciara Metcalfe, Karl A. Merrick	1
3	MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis 2018 ·Proceedings of the National Academy of Sciences ·Lucía Suárez-López, Ganapathy Sriram, Yi Wen Kong, Sandra Morandell, Karl A. Merrick, (unknown), Kevin M. Haigis, Michael B. Yaffe	83
4	A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy 2015 ·Cancer Cell ·Ian G. Cannell, Karl A. Merrick, Sandra Morandell, Chang‐Qi Zhu, Christian Braun, Robert A. Grant, (unknown), Ming‐Sound Tsao, Michael T. Hemann, Michael B. Yaffe	69
5	A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression 2013 ·Molecular Cell ·(unknown), Karl A. Merrick, Stéphane Larochelle, Alexander Hirschi, Chao Zhang, Kevan M. Shokat, Seth M. Rubin, Robert P. Fisher	121
6	Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network 2012 ·Cell Cycle ·Karl A. Merrick, Robert P. Fisher	11
7	Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells 2012 ·PLoS Genetics ·Lara Wohlbold, Karl A. Merrick, Saurav De, Ramon Amat, Jun Hyun Kim, Stéphane Larochelle, Jasmina J. Allen, Chao Zhang, Kevan M. Shokat, John H.J. Petrini, Robert P. Fisher	50
8	Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways 2012 ·Proceedings of the National Academy of Sciences ·Dai Horiuchi, Noelle E. Huskey, Leonard Kusdra, Lara Wohlbold, Karl A. Merrick, Chao Zhang, (unknown), Kevan M. Shokat, Robert P. Fisher, Andrei Goga	64
9	Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation 2011 ·Molecular Cell ·Karl A. Merrick, Lara Wohlbold, Chao Zhang, Jasmina J. Allen, Dai Horiuchi, Noelle E. Huskey, Andrei Goga, Kevan M. Shokat, Robert P. Fisher	69
10	Putting one step before the other: Distinct activation pathways for Cdk1 and Cdk2 bring order to the mammalian cell cycle 2010 ·Cell Cycle ·Karl A. Merrick, Robert P. Fisher	14
11	A virtual cycle: theory and experiment converge on the exit from mitosis 2010 ·F1000 Biology Reports ·Karl A. Merrick, Robert P. Fisher	2
12	Distinct Activation Pathways Confer Cyclin-Binding Specificity on Cdk1 and Cdk2 in Human Cells 2008 ·Molecular Cell ·Karl A. Merrick, Stéphane Larochelle, Chao Zhang, Jasmina J. Allen, Kevan M. Shokat, Robert P. Fisher	77
13	Picosecond-resolution fluorescence lifetime imaging microscopy: a useful tool for sensing molecular interactions in vivo via FRET 2007 ·Optics Express ·Wei Zhong, Mei Wu, Ching‐Wei Chang, Karl A. Merrick, Sofía D. Merajver, Mary‐Ann Mycek	19
14	Requirements for Cdk7 in the Assembly of Cdk1/Cyclin B and Activation of Cdk2 Revealed by Chemical Genetics in Human Cells 2007 ·Molecular Cell ·Stéphane Larochelle, Karl A. Merrick, Marie‐Emilie Terret, Lara Wohlbold, (unknown), Chao Zhang, (unknown), Prasad V. Jallepalli, Robert P. Fisher	207

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact